09.01.05
New findings from a year-and-a-half long study conducted by Professor Peter Jones and his team at McGill University in Canada were recently revealed. The results support the beneficial hypolipidemic effects of carDiabeat, a product developed by Enzymotec. Specifically, the study showed that carDiabeat, with its proprietary combination of natural active lipids, has an overall positive effect on LDL and total cholesterol. It was also shown to improve oxidative stress and the LDL/HDL ratio. carDiabeat can be applied to a variety of formulations, including dietary supplements, nutrition bars and other functional foods and beverages.
For further information: 972-4-6545112
For further information: 972-4-6545112